AAV-MD gene therapy (NightstaRx)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV-MD gene therapy (NightstaRx)
Drug Alias NameNSR AAV-MD gene therapy (NightstaRx)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNightstarTx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNightstarTx Ltd
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A